or Try an Advanced Search...

    ETF Components for CNBS - Amplify Seymour Cannabis ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    IIPR D 1.28 7.93
    TLRY F 2.29 7.08
    MAPS C 2.56 5.80
    GRWG F 0.54 4.02
    SNDL D 0.00 2.66
    REFI A 0.50 2.18
    OGI F 0.66 1.15
    HYFM D 13.58 0.41
    JAZZ B 1.25 0.30
    CARA D -1.58 0.09

    Represented by ETF Holdings

    Keywords: Cannabis Entheogens Euphoriants Medicinal Plants Medicine Aeroponics Biopharmaceutical Cannabis Products Cannabis Smoking Chronic Pain Drugs Health Sciences Herbalism Hydroculture Hydroponics Medical Cannabis Pain Plants Psychoactive Drugs Real Estate Investment Trust
    Industries: Drug Manufacturers - Specialty & Generic Biotechnology Conglomerates Farm & Heavy Construction Machinery Home Improvement Retail REIT - Industrial REIT - Mortgage

    Recent News for Amplify Seymour Cannabis ETF & its Holdings

    Date Stock Title
    Nov 23 TLRY Meta Faces Multibillion-Dollar Lawsuit As Supreme Court Dismisses Appeal In Cambridge Analytica Data Scandal
    Nov 22 IIPR Innovative Industrial Properties: Stock Price Declines Make It More Interesting
    Nov 22 JAZZ ChromaDex Corporation (CDXC) Hits Fresh High: Is There Still Room to Run?
    Nov 22 JAZZ Jazz Pharmaceuticals price target lowered to $163 from $166 at Piper Sandler
    Nov 22 IIPR Innovative Industrial Properties Is Getting Higher On My List
    Nov 21 SNDL SNDL Appoints New Chief Information Officer and New President, Liquor Division
    Nov 21 TLRY German Cannabis: 20 Tons, 10M Grams - And That's Only 0.3% Of The Market, What's Missing?
    Nov 21 TLRY Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee
    Nov 21 SNDL Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee
    Nov 21 TLRY Tilray Brands snapped six straight sessions of losses
    Nov 21 TLRY Redhook Brewery and Montlake Futures Team Up to Launch Montlake Gameday Gold Lager, a New Craft Beer in Support of University of Washington Athletes
    Nov 21 TLRY Tilray Brands Unveils 2024 Holiday Cannabis Gift Guide
    Nov 21 JAZZ Zymeworks, Jazz Pharmaceuticals Receive FDA's Accelerated Approval for Ziihera to Treat Biliary Tract Cancer
    Nov 21 TLRY Tilray Brands Gets Festive with its 2024 Holiday Beverage Gift Guide
    Nov 21 JAZZ Jazz and Zymeworks announce FDA approval of cancer therapy Ziihera
    Nov 21 JAZZ Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)
    Nov 20 TLRY Tilray Brands, Inc. (TLRY) Stock Moves -1.53%: What You Should Know
    Nov 20 TLRY Prediction: Tilray Brands Won't Be a Cannabis Company in 5 Years
    Nov 20 IIPR 3 Dividend Stocks On US Exchanges Offering Up To 7.3% Yield
    Nov 20 TLRY Exploring ACNB And 2 More Undervalued Small Caps With Insider Buying In US
    The investment seeks to provide investors capital appreciation. The fund will invest at least 80% of its net assets (including investment borrowings) in the securities of companies that derive 50% or more of their revenue from the cannabis and hemp ecosystem. It is an actively managed ETF that seeks to provide investment exposure to global companies principally engaged in the emerging cannabis and hemp ecosystem across one of three classifications. The fund is non-diversified.
    Exchange Traded Funds Cannabis Hemp
    Back to the Main CNBS Page...